Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
576.77 USD539.09 USD675.94 USD
+28%
539.09 USDCurrent price is 28% above the base model value.
R
US
REGN.US · REGENERON PHARMACEUTICALS, INC.
US · US
Latest price690.03 USD
30D-9.4%
Vs. base value+30.5%
Research summary
REGN.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +2.09% YoY. Current price is about 690 USD, while the model base case is about 529 USD; the current price sits +30.5% versus the base case. No structured non-recurring items are identified, so valuation defaults to reported figures. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue-
Net income5B USD
Free cash flow5B USD
Operating cash flow5B USD
Price trend
Price date: 2026/04/29 · Updated: 2026/04/29 15:22
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price690.03 USD
Base value528.68 USD
Vs. base+30.5%
Price date2026/04/29
547.53 USD528.68 USD588.41 USD
+30.52%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
589.15 USD632.83 USD658.54 USD
+9.04%
632.83 USDCurrent price is close to the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth1.3%
Current price implies roughly 1.3% annualized FCF growth.
1.3%Current price implies roughly 1.3% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
312.94 USD312.94 USD312.94 USD
+120%
312.94 USDCurrent price is 120.5% above the base model value.
Updated: 2026/04/29 15:22
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
No structured non-recurring items identified. Valuation currently defaults to reported figures and does not claim one-time gains have been removed.
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 14
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | - | 5B USD | - | 5B USD | 41.48 | - |
| 2024/12/31 | Annual | - | 4B USD | - | 4B USD | 38.34 | - |
| 2023/12/31 | Annual | - | 4B USD | - | 5B USD | 34.77 | - |
| 2022/12/31 | Annual | - | 4B USD | - | 5B USD | 38.22 | - |
| 2021/12/31 | Annual | - | 8B USD | - | 7B USD | 71.97 | - |
Ad placement